These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20562652)

  • 41. The 8p11 myeloproliferative syndrome in a 3-year-old child.
    Kuskonmaz B; Kafali C; Akcoren Z; Karabulut HG; Akalin I; Tuncer MA
    Leuk Res; 2008 Jan; 32(1):198-9. PubMed ID: 17555813
    [No Abstract]   [Full Text] [Related]  

  • 42. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
    Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
    Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1.
    Popovici C; Zhang B; Grégoire MJ; Jonveaux P; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Blood; 1999 Feb; 93(4):1381-9. PubMed ID: 9949182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 8p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.
    Antic DA; Vukovic VM; Milosevic Feenstra JD; Kralovics R; Bogdanovic AD; Dencic Fekete MS; Mihaljevic BS
    J BUON; 2016; 21(3):745-9. PubMed ID: 27569099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndrome.
    Shvidel L; Sigler E; Vorst E; Feldberg E; Voskoboinic N; Shtalrid M; Berrebi A
    Leukemia; 2008 Mar; 22(3):644-6. PubMed ID: 17928887
    [No Abstract]   [Full Text] [Related]  

  • 48. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
    Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
    Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature.
    Lv H; Hu S; Lu J; Zhai Q; Zhai Z; Du Z; Sun Y; Li J; He H; Wang Y
    Acta Haematol; 2018; 139(3):176-182. PubMed ID: 29614500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.
    Smedley D; Hamoudi R; Clark J; Warren W; Abdul-Rauf M; Somers G; Venter D; Fagan K; Cooper C; Shipley J
    Hum Mol Genet; 1998 Apr; 7(4):637-42. PubMed ID: 9499416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
    Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual childhood biphenotypic acute leukemia with a yet unreported t(3;13)(p25.1;q13).
    Marques-Salles Tde J; Barros JE; Soares-Ventura EM; Cartaxo Muniz MT; Santos N; Ferreira da Silva E; Silva ML; Liehr T; Mkrtchyan H
    Leuk Res; 2010 Aug; 34(8):e206-7. PubMed ID: 20338638
    [No Abstract]   [Full Text] [Related]  

  • 53. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
    Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of precursor B-lymphoblastic lymphoma/leukaemia of thoracic spine in a pregnancy presenting with acute paraplegia.
    Esin S; Tarim E; Abali H; Kardes O; Kocer EN; Alkan O
    J Obstet Gynaecol; 2012 Jul; 32(5):485-6. PubMed ID: 22663326
    [No Abstract]   [Full Text] [Related]  

  • 55. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
    Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
    Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3.
    Tzankov A; Sotlar K; Muhlematter D; Theocharides A; Went P; Jotterand M; Horny HP; Dirnhofer S
    J Clin Pathol; 2008 Aug; 61(8):958-61. PubMed ID: 18663058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.
    Huang Q; Snyder DS; Chu P; Gaal KK; Chang KL; Weiss LM
    Leukemia; 2011 Feb; 25(2):371-5. PubMed ID: 21304535
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
    Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Büyükçelik A; Yalçin B; Utkan G; Doruk H
    Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
    [No Abstract]   [Full Text] [Related]  

  • 60. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report.
    Niino D; Ohsaki K; Arakawa F; Watanabe J; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Sugita Y; Ohshima K; Okamura T
    Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.